APO RESEARCH · REPORT
1-Butyl-3-methylimidazolium Bromide
1-Butyl-3-methylimidazolium Bromide is a heterocyclic chemical substance identified by its named ring and substituent structure.

Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-3-methylimidazolium Bromide. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 1-Butyl-3-methylimidazolium Bromide?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-3-methylimidazolium Bromide. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Market Structure
Global 1-Butyl-3-methylimidazolium Bromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 1-Butyl-3-methylimidazolium Bromide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 1-Butyl-3-methylimidazolium Bromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 1-Butyl-3-methylimidazolium Bromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 1-Butyl-3-methylimidazolium Bromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 1-Butyl-3-methylimidazolium Bromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 1-Butyl-3-methylimidazolium Bromide include Shandong DYCK Biotech, Jinkai Chemical, Henan Lihua Pharmaceutical and Changzhou Chongkai Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines 1-Butyl-3-methylimidazolium Bromide output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of 1-Butyl-3-methylimidazolium Bromide by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global 1-Butyl-3-methylimidazolium Bromide market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 1-Butyl-3-methylimidazolium Bromide and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 1-Butyl-3-methylimidazolium Bromide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 1-Butyl-3-methylimidazolium Bromide market size, projected growth trends, production technologies, key applications, and end-use industries.
1-Butyl-3-methylimidazolium Bromide Segment by Company
Shandong DYCK Biotech
Jinkai Chemical
Henan Lihua Pharmaceutical
Changzhou Chongkai Chemical
1-Butyl-3-methylimidazolium Bromide Segment by Type
≥99.0% Purity
<99.0% Purity
1-Butyl-3-methylimidazolium Bromide Segment by Application
Plasticizer
Other
1-Butyl-3-methylimidazolium Bromide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1-Butyl-3-methylimidazolium Bromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 1-Butyl-3-methylimidazolium Bromide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1-Butyl-3-methylimidazolium Bromide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 1-Butyl-3-methylimidazolium Bromide market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 1-Butyl-3-methylimidazolium Bromide industry.
Chapter 3: Detailed analysis of 1-Butyl-3-methylimidazolium Bromide market competition landscape. Including 1-Butyl-3-methylimidazolium Bromide manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of 1-Butyl-3-methylimidazolium Bromide by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of 1-Butyl-3-methylimidazolium Bromide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ≥99.0% Purity
- <99.0% Purity
Applications
- Plasticizer
- Other
Companies covered
- Shandong DYCK Biotech
- Jinkai Chemical
- Henan Lihua Pharmaceutical
- Changzhou Chongkai Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 1-Butyl-3-methylimidazolium Bromide Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global 1-Butyl-3-methylimidazolium Bromide Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global 1-Butyl-3-methylimidazolium Bromide Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global 1-Butyl-3-methylimidazolium Bromide Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global 1-Butyl-3-methylimidazolium Bromide Market Dynamics
- 2.1 1-Butyl-3-methylimidazolium Bromide Industry Trends
- 2.2 1-Butyl-3-methylimidazolium Bromide Industry Drivers
- 2.3 1-Butyl-3-methylimidazolium Bromide Industry Opportunities and Challenges
- 2.4 1-Butyl-3-methylimidazolium Bromide Industry Restraints
3 1-Butyl-3-methylimidazolium Bromide Market by Manufacturers
- 3.1 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Manufacturers (2021-2026)
- 3.2 Global 1-Butyl-3-methylimidazolium Bromide Production by Manufacturers (2021-2026)
- 3.3 Global 1-Butyl-3-methylimidazolium Bromide Average Price by Manufacturers (2021-2026)
- 3.4 Global 1-Butyl-3-methylimidazolium Bromide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 1-Butyl-3-methylimidazolium Bromide Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 1-Butyl-3-methylimidazolium Bromide Manufacturers, Product Type & Application
- 3.7 Global 1-Butyl-3-methylimidazolium Bromide Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 1-Butyl-3-methylimidazolium Bromide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 1-Butyl-3-methylimidazolium Bromide Players Market Share by Production Value in 2025
- 3.8.3 2025 1-Butyl-3-methylimidazolium Bromide Tier 1, Tier 2, and Tier 3
4 1-Butyl-3-methylimidazolium Bromide Market by Type
- 4.1 1-Butyl-3-methylimidazolium Bromide Type Introduction
- 4.1.1 ≥99.0% Purity
- 4.1.2 <99.0% Purity
- 4.2 Global 1-Butyl-3-methylimidazolium Bromide Production by Type
- 4.2.1 Global 1-Butyl-3-methylimidazolium Bromide Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 1-Butyl-3-methylimidazolium Bromide Production by Type (2021-2032)
- 4.2.3 Global 1-Butyl-3-methylimidazolium Bromide Production Market Share by Type (2021-2032)
- 4.3 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Type
- 4.3.1 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Type (2021-2032)
- 4.3.3 Global 1-Butyl-3-methylimidazolium Bromide Production Value Market Share by Type (2021-2032)
5 1-Butyl-3-methylimidazolium Bromide Market by Application
- 5.1 1-Butyl-3-methylimidazolium Bromide Application Introduction
- 5.1.1 Plasticizer
- 5.1.2 Other
- 5.2 Global 1-Butyl-3-methylimidazolium Bromide Production by Application
- 5.2.1 Global 1-Butyl-3-methylimidazolium Bromide Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 1-Butyl-3-methylimidazolium Bromide Production by Application (2021-2032)
- 5.2.3 Global 1-Butyl-3-methylimidazolium Bromide Production Market Share by Application (2021-2032)
- 5.3 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Application
- 5.3.1 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Application (2021-2032)
- 5.3.3 Global 1-Butyl-3-methylimidazolium Bromide Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Shandong DYCK Biotech
- 6.1.1 Shandong DYCK Biotech Company Information
- 6.1.2 Shandong DYCK Biotech Business Overview
- 6.1.3 Shandong DYCK Biotech 1-Butyl-3-methylimidazolium Bromide Production, Value and Gross Margin (2021-2026)
- 6.1.4 Shandong DYCK Biotech 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.1.5 Shandong DYCK Biotech Recent Developments
- 6.2 Jinkai Chemical
- 6.2.1 Jinkai Chemical Company Information
- 6.2.2 Jinkai Chemical Business Overview
- 6.2.3 Jinkai Chemical 1-Butyl-3-methylimidazolium Bromide Production, Value and Gross Margin (2021-2026)
- 6.2.4 Jinkai Chemical 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.2.5 Jinkai Chemical Recent Developments
- 6.3 Henan Lihua Pharmaceutical
- 6.3.1 Henan Lihua Pharmaceutical Company Information
- 6.3.2 Henan Lihua Pharmaceutical Business Overview
- 6.3.3 Henan Lihua Pharmaceutical 1-Butyl-3-methylimidazolium Bromide Production, Value and Gross Margin (2021-2026)
- 6.3.4 Henan Lihua Pharmaceutical 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.3.5 Henan Lihua Pharmaceutical Recent Developments
- 6.4 Changzhou Chongkai Chemical
- 6.4.1 Changzhou Chongkai Chemical Company Information
- 6.4.2 Changzhou Chongkai Chemical Business Overview
- 6.4.3 Changzhou Chongkai Chemical 1-Butyl-3-methylimidazolium Bromide Production, Value and Gross Margin (2021-2026)
- 6.4.4 Changzhou Chongkai Chemical 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.4.5 Changzhou Chongkai Chemical Recent Developments
7 Global 1-Butyl-3-methylimidazolium Bromide Production by Region
- 7.1 Global 1-Butyl-3-methylimidazolium Bromide Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global 1-Butyl-3-methylimidazolium Bromide Production by Region (2021-2032)
- 7.2.1 Global 1-Butyl-3-methylimidazolium Bromide Production by Region (2021-2026)
- 7.2.2 Global 1-Butyl-3-methylimidazolium Bromide Production Forecast by Region (2027-2032)
- 7.3 Global 1-Butyl-3-methylimidazolium Bromide Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Region (2021-2032)
- 7.4.1 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Region (2021-2026)
- 7.4.2 Global 1-Butyl-3-methylimidazolium Bromide Production Value by Region (2027-2032)
- 7.5 Global 1-Butyl-3-methylimidazolium Bromide Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America 1-Butyl-3-methylimidazolium Bromide Production Value (2021-2032)
- 7.6.2 Europe 1-Butyl-3-methylimidazolium Bromide Production Value (2021-2032)
- 7.6.3 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Production Value (2021-2032)
- 7.6.4 South America 1-Butyl-3-methylimidazolium Bromide Production Value (2021-2032)
- 7.6.5 Middle East & Africa 1-Butyl-3-methylimidazolium Bromide Production Value (2021-2032)
8 Global 1-Butyl-3-methylimidazolium Bromide Consumption by Region
- 8.1 Global 1-Butyl-3-methylimidazolium Bromide Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global 1-Butyl-3-methylimidazolium Bromide Consumption by Region (2021-2032)
- 8.2.1 Global 1-Butyl-3-methylimidazolium Bromide Consumption by Region (2021-2026)
- 8.2.2 Global 1-Butyl-3-methylimidazolium Bromide Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America 1-Butyl-3-methylimidazolium Bromide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America 1-Butyl-3-methylimidazolium Bromide Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe 1-Butyl-3-methylimidazolium Bromide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe 1-Butyl-3-methylimidazolium Bromide Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific 1-Butyl-3-methylimidazolium Bromide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific 1-Butyl-3-methylimidazolium Bromide Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America 1-Butyl-3-methylimidazolium Bromide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America 1-Butyl-3-methylimidazolium Bromide Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa 1-Butyl-3-methylimidazolium Bromide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa 1-Butyl-3-methylimidazolium Bromide Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 1-Butyl-3-methylimidazolium Bromide Value Chain Analysis
- 9.1.1 1-Butyl-3-methylimidazolium Bromide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 1-Butyl-3-methylimidazolium Bromide Production Mode & Process
- 9.2 1-Butyl-3-methylimidazolium Bromide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 1-Butyl-3-methylimidazolium Bromide Distributors
- 9.2.3 1-Butyl-3-methylimidazolium Bromide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst